GLANZMANN THROMBASTHENIA
Clinical trials for GLANZMANN THROMBASTHENIA explained in plain language.
Never miss a new study
Get alerted when new GLANZMANN THROMBASTHENIA trials appear
Sign up with your email to follow new studies for GLANZMANN THROMBASTHENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for controlling dangerous bleeding in rare disorder
Disease control Recruiting nowThis study is testing an investigational drug called eptacog beta to see if it can safely and effectively treat and prevent serious bleeding episodes in people with Glanzmann Thrombasthenia, a rare inherited bleeding disorder. Six participants with a history of severe bleeding wi…
Matched conditions: GLANZMANN THROMBASTHENIA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists search for genetic clues behind rare bleeding disorders
Knowledge-focused Recruiting nowThis research study aims to better understand how inherited blood cell disorders develop by examining blood samples from patients and healthy volunteers. Researchers will perform advanced laboratory tests on platelets and other blood components, and analyze genetic material to id…
Matched conditions: GLANZMANN THROMBASTHENIA
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC